Pure Global AI
NCT06252818Not yet recruiting

Validation of a Digital Platform for Functional Respiratory Rehabilitation

Validation of a Digital Platform for Functional Respiratory Rehabilitation (ReHub)
Bio-Sensing Solutions S.L. (DyCare)ClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
COPD
Drug/Device/Intervention
ReHub
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Bio-Sensing Solutions S.L. (DyCare)
Location
Barcelona, Spain
Timeline & enrollment
Phase
N/A
Start date
Mar 07, 2024
End date
Dec 01, 2024
Enrollment
100 participants
Primary outcome

System Usability Scale (SUS),Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications (pSUAPP-S) for Patients,Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications (pSUAPP-S) for Healthcare Professionals

Summary

Chronic Obstructive Pulmonary Disease (COPD), characterized by persistent airflow limitation
 in the respiratory airways, is a chronic condition that affects millions of people worldwide.
 ReHub enables healthcare professionals to design therapeutic exercise programs for the
 treatment of COPD patients, as well as to analyze and monitor patient rehabilitation through
 the information and feedback provided via the platform. The main objective of the study is to
 evaluate the satisfaction and usability of the ReHub platform (for respiratory
 rehabilitation) among COPD patients and healthcare professionals. This is a single-center
 satisfaction and usability study on the usage and experience of the ReHub platform (for
 respiratory rehabilitation).

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedPulmonary heart disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06252818
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06252818 through Pure Global AI's free database. This phase not specified trial is sponsored by Bio-Sensing Solutions S.L. (DyCare) and is currently Not yet recruiting. The study focuses on COPD. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.